CIK 0001393434
- Large accelerated filer
OCULAR THERAPEUTIX, INC
Sign in to watch- Ticker
- OCUL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 781-357-4000
- Business address
- 14 CROSBY DRIVE, 3RD FLOOR, BEDFORD, MA, 01730
- Former names
- I-THERAPEUTIX INC
- 4 Planned sale Dugel Pravin sold 20,880 shares at $9.02 ($188,338)
- 4 Exercise or conversion Director acquired 30,302 shares (option exercise)
- 4 Grant or award Director acquired 12,000 shares (grant or award)
- 4 Grant or award Director acquired 12,000 shares (grant or award)
- 4 Grant or award Director acquired 12,000 shares (grant or award)
- 4 Grant or award Director acquired 12,000 shares (grant or award)
- 4 Grant or award Director acquired 12,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 141,666 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Strategy Officer sold 2,274 shares at $5.84 ($13,280)
- 4 Planned sale Dugel Pravin sold 21,626 shares at $5.79 ($125,215)
- 4 Open-market buy 10% owner bought 930,851 shares at $7.52 ($7,000,000)
- 4 Grant or award Executive Chairman acquired 854,979 shares (grant or award)
- 4 Grant or award Chief Strategy Officer acquired 80,300 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Business Officer sold 5,910 shares at $4.86 ($28,723)
- 4 Open-market sale General Counsel sold 6,029 shares at $4.86 ($29,301)
- 4 Open-market sale Chief Medical Officer sold 6,346 shares at $4.86 ($30,842)
- 4 Open-market sale Chief Financial Officer sold 6,212 shares at $4.86 ($30,190)
Page 6 of 18 · 354 filings